Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Research highlight

Molecular fingerprinting catches responders to therapeutic agents

Simeen Malik1*, Patrick Tan123 and Pauline C Ng4

Author Affiliations

1 Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore

2 Infectious Diseases, Genome Institute of Singapore, 60 Biopolis Street, Genome, #02-01, Singapore 138672, Singapore

3 Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, 14 Medical Drive, #12-01, Singapore 117599, Singapore

4 Computational and Mathematical Biology, Genome Institute of Singapore, 60 Biopolis Street, Genome, #02-01, Singapore 138672, Singapore

For all author emails, please log on.

Genome Biology 2013, 14:135  doi:10.1186/gb-2013-14-10-135


See related Research, http://genomebiology.com/2013/14/10/R110

Published: 31 October 2013

Abstract

High-dimensional -omics profiling predicts responses to therapeutic agents in breast cancer cell lines that can be effectively applied to patient selection in clinical trials.